image
Healthcare - Biotechnology - NASDAQ - US
$ 1.55
-12.3 %
$ 87.8 M
Market Cap
-1.15
P/E
BALANCE SHEET
123 M ASSETS
-22.66%
39.4 M LIABILITIES
-5.92%
83.3 M EQUITY
-28.66%
BALANCE SHEET DECOMPOSITION
Balance Sheet Black Diamond Therapeutics, Inc.
image
Current Assets 101 M
Cash & Short-Term Investments 98.6 M
Receivables 0
Other Current Assets 2.6 M
Non-Current Assets 21.5 M
Long-Term Investments 0
PP&E 20.4 M
Other Non-Current Assets 1.07 M
80.38 %16.63 %Total Assets$122.6m
Current Liabilities 20.6 M
Accounts Payable 4.01 M
Short-Term Debt 0
Other Current Liabilities 16.6 M
Non-Current Liabilities 18.8 M
Long-Term Debt 0
Other Non-Current Liabilities 18.8 M
10.18 %42.09 %47.72 %Total Liabilities$39.4m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 36.4 56.2 34.3 65.8 34.6 154.7 51.7 7.9
Short Term Investments 62.1 75.2 88.5 144.0 280.5 0 0 0
Receivables 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0
Other Current Assets 2.6 2.6 4.9 5.9 4.5 2.1 24 K 36 K
Total Current Assets 101.2 134.0 127.7 209.8 319.6 154.7 51.7 7.9
PP&E 20.4 23.7 27.4 30.7 8.8 0.2 0.1 0.1
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 0 0 1.2 1.2 1.2 55 K 0 0
Other Long Term Assets 1.1 0.8 0 5.9 0.1 3.4 8 K 5 K
Other Assets 0 0 0 0 0 0 0 0
Total Assets 122.6 158.6 156.3 247.7 329.7 158.3 51.8 8.0
LIABILITIES
Accounts Payable 4.0 2.3 1.9 4.1 2.5 2.0 0.4 0.2
Short Term Debt 0 3.1 2.8 0.3 1.0 0 0 0
Other Current Liabilities 16.6 14.2 10.5 19.2 10.6 2.9 2.2 2.1
Total Current Liabilities 20.6 19.6 15.3 23.6 14.2 4.9 2.6 2.2
Long Term Debt 0 22.2 25.3 28.1 7.7 0 60.8 0
Deferred Tax Income 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 200.6 4.0 12.5
Total Liabilities 39.4 41.8 40.6 491.5 21.9 209.3 67.4 14.7
EQUITY
Common Stock 7 K 7 K 5 K 5 K 5 K 1 K 1 K 1 K
Retained Earnings (487.1) (417.4) (335.0) (243.8) (118.2) (51.0) (15.7) (6.8)
Other Accumulative Comprehensive Income/Loss 24 K 27 K (1.8) (0.4) 0.6 1 K 100 K 56 K
Total Equity 83.3 116.7 (335.0) (243.8) (118.2) (51.0) (15.5) (6.7)
Total Liabilities and Equity 122.6 158.6 (294.4) 247.7 (96.3) 158.3 51.8 8.0
SHARES OUTSTANDING
Common Shares Outstanding 55.0 44.0 36.3 36.2 32.9 35.9 14.0 7.2